Full Text Journal Articles by
Author Jay D Raman

Advertisement

Find full text journal articles






EDITORIAL COMMENT.

Lydia Glick, Sage A Vincent, Danielle Squadron, Timothy M Han, Kanata Syed, John F Danella, Serge Ginzburg, Thomas J Guzzo, Thomas Lanchoney, Jay D Raman, Marc Smaldone, Robert G Uzzo, Jeffrey J Tomaszweski, Adam Reese, Eric A Singer, Bruce Jacobs, Edouard J Trabulsi, Leonard G Gomella, Mark J Mann,

Urology (Urology)
[2021, 155:18]

Cited: 0 times

View full text PDF listing >>



Primary Chemoablation of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Using UGN-102, A Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.

K Kent Chevli, Neal D Shore, Andrew Trainer, Angela B Smith, Daniel Saltzstein, Yaron Ehrlich, Jay D Raman, Boris Friedman, Richard D'Anna, David Morris, Brian Hu, Mark Tyson, Alexander Sankin, Max Kates, Jennifer Linehan, Douglas Scherr, Steven Kester, Michael Verni, Karim Chamie, Lawrence Karsh, Arnold Cinman, Andrew Meads, Soumi Lahiri, Madlen Malinowski, Nimrod Gabai, Sunil Raju, Mark Schoenberg, Elyse Seltzer, William C Huang,

<h4>Purpose</h4>Low-grade intermediate-risk non-muscle-invasive bladder cancer (LG IR NMIBC) is a recurrent disease, thus requiring repeated transurethral resection of bladder tumors (TURBT) under general anesthesia. We evaluated the efficacy and safety of UGN-102, a mitomycin-containing reverse thermal gel, as a primary chemoablative therapeutic alternative to TURBT for patients with LG IR ... Read more >>

J Urol (The Journal of urology)
[2021, :101097JU0000000000002186]

Cited: 0 times

View full text PDF listing >>



Advertisement

The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma.

Jay D Raman, Laimonis Kavalieris, Badrinath Konety, Sima Porten, Siamak Daneshmand, Yair Lotan, Ronald Loo,

<h4>Purpose</h4>Cxbladder (Cxb) tests combine genomic biomarkers in urine with phenotypic and clinical data to classify hematuria patients into those at low/high probability of urothelial carcinoma (UC). Cxbladder Resolve (CxbR) is designed for use after Cxb Triage (CxbT) and Detect (CxbD), where CxbT-positive tests reflex to CxbD and CxbD-positive to CxbR ... Read more >>

J Urol (The Journal of urology)
[2021, :101097JU0000000000002135]

Cited: 0 times

View full text PDF listing >>



Bladder Chemoprophylaxis Following Ureterorenoscopy in Patients with Upper Tract Urothelial Carcinoma.

Federico Ferraris, Jay D Raman, Fabian Yaber,

Kidney-sparing procedures for upper tract urothelial carcinoma (UTUC) have evolved from imperative to elective indications for management of low-risk disease. Ureterorenoscopy is the most common procedure for the diagnosis, treatment, and surveillance of UTUC. A notable consideration following ureterorenoscopy is the higher risk of downstream bladder seeding. Here we review ... Read more >>

Eur Urol Focus (European urology focus)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.

Rashed A Ghandour, Yuval Freifeld, Joseph Cheaib, Nirmish Singla, Xiaosong Meng, Alexander Kenigsberg, Aditya Bagrodia, Solomon Woldu, Jean Hoffman-Censits, Dmitry Enikeev, Leonid Rapoport, Firas G Petros, Jay D Raman, Philip M Pierorazio, Surena F Matin, Vitaly Margulis,

<h4>Introduction</h4>Neoadjuvant chemotherapy (NAC) is increasingly used prior to radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Systemic recurrence (SR) carries a dismal prognosis. We sought to determine risk factors associated with SR in this setting.<h4>Methods</h4>We evaluated a multi-center database of patients with UTUC who received cisplatin-based NAC before RNU. ... Read more >>

Urol Oncol (Urologic oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Warm ischemia time length during on-clamp partial nephrectomy: dose it really matter?

Ali Abdel Raheem, Ibrahim Alowidah, Umberto Capitanio, Francesco Montorsi, Alessandro Larcher, Ithaar Derweesh, Fady Ghali, Alexader Mottrie, Elio Mazzone, Geert DE Naeyer, Riccardo Campi, Francesco Sessa, Marco Carini, Andrea Minervini, Jay D Raman, Chris J Rjepaj, Maximilian C Kriegmair, Riccardo Autorino, Alessandro Veccia, Maria Carmen Mir, Francesco Claps, Young Deuk Choi, Won S Ham, John P Tadifa, Glen D Santok, Maria Furlan, Claudio Simeone, Maida Bada, Antonio Celia, Diego M Carrion, Alfredo Aguilera Bazan, Cristina B Ruiz, Manar Malki, Neil Barber, Muddassar Hussain, Salvatore Micali, Stefano Puliatti, Abdelaziz Alwahabi, Abdulrahman Alqahtani, Abdullah Rumaih, Ahmed Ghaith, Ayman M Ghoneem, Ayman Hagras, Ahmed Eissa, Mohammed J Alenzi, Nicola Pavan, Fabio Traunero, Alessandro Antonelli, Antonio B Porcaro, Ester Illiano, Elisabetta Costantini, Koon H Rha,

<h4>Background</h4>The impact of warm ischemia time (WIT) on renal functional recovery remains controversial. We examined the length of WIT >30 min. on the long-term renal function following on-clamp partial nephrectomy (PN).<h4>Methods</h4>Data from 23 centers for patients undergoing on-clamp PN between 2000 and 2018 were analyzed. We included patients with two ... Read more >>

Minerva Urol Nephrol (Minerva urology and nephrology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic.

Adrien N Bernstein, Ruchika Talwar, Elizabeth Handorf, Kaynaat Syed, John Danella, Serge Ginzburg, Laurence Belkoff, Adam C Reese, Jeffery Tomaszewski, Edouard Trabulsi, Eric A Singer, Bruce Jacobs, Alexander Kutikov, Robert Uzzo, Jay D Raman, Thomas Guzzo, Marc C Smaldone, Andres Correa,

<h4>Importance</h4>Early in the COVID-19 pandemic, racial/ethnic minority communities disproportionately experienced poor outcomes; however, the association of the pandemic with prostate cancer (PCa) care is unknown.<h4>Objective</h4>To assess the association between race and PCa care delivery for Black and White patients during the first wave of the COVID-19 pandemic.<h4>Design, setting, and participants</h4>This ... Read more >>

JAMA Oncol (JAMA oncology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Potential Winners and Losers: Understanding How the Oncology Care Model May Differentially Affect Hospitals.

Joel E Segel, Eric W Schaefer, Nicholas G Zaorsky, Christopher S Hollenbeak, Haleh Ramian, Jay D Raman,

<h4>Purpose</h4>With the introduction of the Oncology Care Model and plans for the transition to Oncology Care First, alternative payment models (APMs) are an increasingly important piece of the oncology care landscape. Evidence is mixed on the Oncology Care Model's impact on utilization and costs, but as policymakers consider expansion of ... Read more >>

JCO Oncol Pract (JCO oncology practice)
[2021, 17(8):e1150-e1161]

Cited: 0 times

View full text PDF listing >>



The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer - a multicentre observational study.

Sinan Khadhouri, Kevin M Gallagher, Kenneth R MacKenzie, Taimur T Shah, Chuanyu Gao, Sacha Moore, Eleanor F Zimmermann, Eric Edison, Matthew Jefferies, Arjun Nambiar, Miles P Mannas, Taeweon Lee, Giancarlo Marra, Beatrice Lillaz, Juan Gómez Rivas, Jonathan Olivier, Mark A Assmus, Taha Uçar, Francesco Claps, Matteo Boltri, Tara Burnhope, Nkwam Nkwam, George Tanasescu, Nicholas E Boxall, Alison P Downey, Asim A Lal, Marta Antón-Juanilla, Holly Clarke, David H W Lau, Kathryn Gillams, Matthew Crockett, Matthew Nielsen, Yemisi Takwoingi, Naomi Chuchu, John O'Rourke, Graeme MacLennan, John S McGrath, Veeru Kasivisvanathan, ,

<h4>Objective</h4>To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper tract urothelial cancer [UTUC] and renal cancer) in patients referred to secondary care with haematuria, adjusted for established patient risk markers and geographical variation.<h4>Patients and methods</h4>This was an international multicentre prospective observational study. We included patients aged ≥16 years, ... Read more >>

BJU Int (BJU international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Association between urinary arsenic, blood cadmium, blood lead, and blood mercury levels and serum prostate-specific antigen in a population-based cohort of men in the United States.

Hongke Wu, Ming Wang, Jay D Raman, Alicia C McDonald,

Exposures to heavy metals have been linked to prostate cancer risk. The relationship of these exposures with serum prostate-specific antigen (PSA), a marker used for prostate cancer screening, is unknown. We examined whether total urinary arsenic, urinary dimethylarsonic acid, blood cadmium, blood lead, and total blood mercury levels are associated ... Read more >>

PLoS One (PloS one)
[2021, 16(4):e0250744]

Cited: 0 times

View full text PDF listing >>



Laboratory Reporting Parameters of Microhematuria: Implications for Interpreting the 2020 AUA Guideline.

Kevan M Sternberg, Mohannad A Awad, Mackenzie Goldsmith, Luke A Hallgarth, Jay D Raman,

<h4>Objective</h4>To explore how laboratories in the United States (U.S.) report red blood cell per high powered field (RBC/HPF) counts on urinalysis and to evaluate whether this methodology permits effective risk stratification in accordance with the 2020 AUA/SUFU microhematuria guidelines.<h4>Materials and methods</h4>Reporting methods for RBC/HPF counts (ranges, or actual counts) were ... Read more >>

Urology (Urology)
[2021, 154:24-27]

Cited: 0 times

View full text PDF listing >>



Pathological characteristics of the large renal mass: potential implication for clinical role of renal biopsy.

Aeen M Asghar, Andrew G McIntosh, Zachary L Smith, Neil J Kocher, Ziho Lee, Nimrod N Barashi, Tianyu Li, Jay D Raman, Scott E Eggener, Robert G Uzzo, Alexander Kutikov,

<h4>Introduction</h4>To assess whether patients with a large renal mass, treated by radical nephrectomy (RN), could have benefited from preoperative renal mass biopsy (RMB). The decision to perform partial nephrectomy (PN) for an organ-confined > 4 cm renal mass can be complex. Albeit often feasible, oncologic safety of PN in this ... Read more >>

Can J Urol (The Canadian journal of urology)
[2021, 28(2):10620-10624]

Cited: 0 times

View full text PDF listing >>



An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.

Sia Viborg Lindskrog, Frederik Prip, Philippe Lamy, Ann Taber, Clarice S Groeneveld, Karin Birkenkamp-Demtröder, Jørgen Bjerggaard Jensen, Trine Strandgaard, Iver Nordentoft, Emil Christensen, Mateo Sokac, Nicolai J Birkbak, Lasse Maretty, Gregers G Hermann, Astrid C Petersen, Veronika Weyerer, Marc-Oliver Grimm, Marcus Horstmann, Gottfrid Sjödahl, Mattias Höglund, Torben Steiniche, Karin Mogensen, Aurélien de Reyniès, Roman Nawroth, Brian Jordan, Xiaoqi Lin, Dejan Dragicevic, Douglas G Ward, Anshita Goel, Carolyn D Hurst, Jay D Raman, Joshua I Warrick, Ulrika Segersten, Danijel Sikic, Kim E M van Kessel, Tobias Maurer, Joshua J Meeks, David J DeGraff, Richard T Bryan, Margaret A Knowles, Tatjana Simic, Arndt Hartmann, Ellen C Zwarthoff, Per-Uno Malmström, Núria Malats, Francisco X Real, Lars Dyrskjøt,

The molecular landscape in non-muscle-invasive bladder cancer (NMIBC) is characterized by large biological heterogeneity with variable clinical outcomes. Here, we perform an integrative multi-omics analysis of patients diagnosed with NMIBC (n = 834). Transcriptomic analysis identifies four classes (1, 2a, 2b and 3) reflecting tumor biology and disease aggressiveness. Both transcriptome-based subtyping ... Read more >>

Nat Commun (Nature communications)
[2021, 12(1):2301]

Cited: 2 times

View full text PDF listing >>



Preventing Prostate Biopsy Complications: to Augment or to Swab?

Lydia Glick, Sage A Vincent, Danielle Squadron, Timothy M Han, Kanata Syed, John F Danella, Serge Ginzburg, Thomas J Guzzo, Thomas Lanchoney, Jay D Raman, Marc Smaldone, Robert G Uzzo, Jeffrey J Tomaszweski, Adam Reese, Eric A Singer, Bruce Jacobs, Edouard J Trabulsi, Leonard G Gomella, Mark J Mann,

<h4>Objective</h4>To use data from a large, prospectively- acquired regional collaborative database to compare the risk of infectious complications associated with three American Urologic Association- recommended antibiotic prophylaxis pathways, including culture-directed or augmented antibiotics, following prostate biopsy.<h4>Methods</h4>Data on prostate biopsies and outcomes were collected from the Pennsylvania Urologic Regional Collaborative, a ... Read more >>

Urology (Urology)
[2021, 155:12-19]

Cited: 0 times

View full text PDF listing >>



Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer.

Tejaswi Iyyanki, Baozhen Zhang, Qixuan Wang, Ye Hou, Qiushi Jin, Jie Xu, Hongbo Yang, Tingting Liu, Xiaotao Wang, Fan Song, Yu Luan, Hironobu Yamashita, Ruby Chien, Huijue Lyu, Lijun Zhang, Lu Wang, Joshua Warrick, Jay D Raman, Joshua J Meeks, David J DeGraff, Feng Yue,

Muscle-invasive bladder cancers are characterized by their distinct expression of luminal and basal genes, which could be used to predict key clinical features such as disease progression and overall survival. Transcriptionally, FOXA1, GATA3, and PPARG are shown to be essential for luminal subtype-specific gene regulation and subtype switching, while TP63, ... Read more >>

Genome Biol (Genome biology)
[2021, 22(1):105]

Cited: 0 times

View full text PDF listing >>



The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma.

Bashir Al Hussein Al Awamlh, Jonathan E Shoag, Spyridon P Basourakos, Patrick J Lewicki, Lina Posada, Xiaoyue Ma, Jay D Raman, Shahrokh F Shariat, Douglas Scherr,

<h4>Objective</h4>To determine factors associated with performing inadvertent radical nephrectomy (RN) for upper tract urothelial carcinoma (UTUC), and to assess the impact of radical nephrectomy on overall survival (OS) compared to radical nephroureterectomy (NU).<h4>Methods</h4>Using the National Cancer Database (NCDB), patients with UTUC of the renal pelvis who were diagnosed with renal ... Read more >>

Urology (Urology)
[2021, 154:127-135]

Cited: 0 times

View full text PDF listing >>



Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer?

R Grant Owens, Justin Loloi, Erik B Lehman, Matthew G Kaag, Jay D Raman, Suzanne B Merrill,

<h4>Objectives</h4>The American Urological Association's (AUA) and National Comprehensive Cancer Network's (NCCN) provide highly recognized guidelines for staging prostate cancer (CaP). However, both are vague as to specific type of cross-sectional imaging (CT vs. MRI) and extent (abdominal vs. pelvis), thereby raising concern for overlapping imaging. We investigated if current AUA ... Read more >>

Urol Oncol (Urologic oncology)
[2021, 39(7):433.e9-433.e15]

Cited: 0 times

View full text PDF listing >>



Widely Variable Parental Leave Practices for Urology Residency Programs in the United States.

Susan M MacDonald, Jay D Raman,

<h4>Objective</h4>To query a cohort of program directors to better understand the contemporary landscape of parental leave for urology trainees. The American Board of Urology mandates that a resident must work 46 weeks annually in order to not extend residency. We hypothesize that formal parental leave policies may vary by institution ... Read more >>

Urology (Urology)
[2021, 153:81-86]

Cited: 0 times

View full text PDF listing >>



Microhematuria: AUA/SUFU Guideline. Letter.J Urol 2020; 204: 778.

Richard S Matulewicz, Jay D Raman,

J Urol (The Journal of urology)
[2021, 205(5):1533-1534]

Cited: 0 times

View full text PDF listing >>



Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis.

Zine-Eddine Khene, Gilles Dosin, Benoit Peyronnet, Anis Gasmi, Nicolas Doumerc, Idir Ouzaid, Benjamin Pradere, Marie Brassier, Mathieu Roumiguié, Romain Mathieu, Nathalie Rioux-Leclercq, Jay D Raman, Shahrokh Shariat, Karim Bensalah,

To investigate the association of adherent perinephric fat (APF) with perioperative outcomes, we conducted a systematic review and meta-analysis of the literature to clarify the impact of APF in patients undergoing partial nephrectomy. A systematic literature search using the Medline, Scopus, and Cochrane databases was performed in April 2019 and ... Read more >>

Int J Clin Oncol (International journal of clinical oncology)
[2021, 26(4):636-646]

Cited: 0 times

View full text PDF listing >>



The Significance of Preoperative Serum Sodium and Hemoglobin in Outcomes of Upper Tract Urothelial Carcinoma: Multi-Center Analysis Between China and the United States.

Dong Fang, Nirmish Singla, Zhengqing Bao, Syed M Jafri, Xiaohong Su, Zhenpeng Cao, Gengyan Xiong, Lei Zhang, Solomon Woldu, Ryan Hutchinson, Arthur Sagalowsky, Yair Lotan, Xuesong Li, Jay D Raman, Vitaly Margulis, Liqun Zhou,

<h4>Purpose</h4>To analyze the effect of preoperative serum sodium and hemoglobin on oncologic outcomes in upper tract urothelial carcinoma (UTUC) based on a multi-center cohort from China and the United States (U.S.).<h4>Methods</h4>We retrospectively reviewed the records of 775 patients with UTUC treated surgically at tertiary care medical facilities in China or ... Read more >>

Cancer Manag Res (Cancer management and research)
[2020, 12:9825-9836]

Cited: 0 times

View full text PDF listing >>



Endoscopic Closure of a Large Rectovesical Fistula Following Robotic Prostatectomy.

Andrew Watts, Neil J Kocher, Eric Pauli, Jay D Raman,

<b><i>Background:</i></b> Rectovesical fistulae (RVF) are uncommon complications of pelvic surgeries and are a potential cause of significant morbidity. RVF are not typically closed endoscopically but rather require reoperative surgery of the lower pelvis with closure of tract, interposition of fat or omentum, and possible permanent bowel diversion. We present a ... Read more >>

J Endourol Case Rep (Journal of endourology case reports)
[2020, 6(3):139-142]

Cited: 0 times

View full text PDF listing >>



An editorial comment for the special series "Upper-Tract Urothelial Carcinoma: Current State and Future Directions".

John J Knoedler, Jay D Raman,

Transl Androl Urol (Translational andrology and urology)
[2020, 9(4):1778-1779]

Cited: 0 times

View full text PDF listing >>



Histologic Heterogeneity of Extirpated Renal Cell Carcinoma Specimens: Implications for Renal Mass Biopsy.

Lauren M Nahouraii, Jordan L Allen, Suzanne B Merrill, Erik Lehman, Matthew G Kaag, Jay D Raman,

Pathologic characteristics of extirpated renal cell carcinoma (RCC) specimens <7 cm were reviewed to get better information on technical nuances of renal mass biopsy (RMB). Specimens were stratified according to tumor stage, nuclear grade, size, histology, presence of lymphovascular invasion (LVI), necrosis, and sarcomatoid features. When considering pT1 (0-7 cm) ... Read more >>

J Kidney Cancer VHL (Journal of kidney cancer and VHL)
[2020, 7(3):20-25]

Cited: 0 times

View full text PDF listing >>



Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma.

Leo D Dreyfuss, Viraj A Master, Jay D Raman, Philippe E Spiess, Shane A Wells, Suzanne B Merrill, Charles C Peyton, Dhyana Sankar, Brian Sohl, Dattatraya Patil, Daniel D Shapiro, Glenn O Allen, E Jason Abel,

<b>Objective: </b>To evaluate postoperative recurrence patterns for high-risk nonmetastatic renal cell carcinoma (RCC) and to identify prognostic factors associated with site-specific metastatic recurrence using a multi-institutional contemporary cohort.<br><br><b>Methods: </b>Data for nonmetastatic ≥pT3a RCC patients treated with surgery at 4 independent centers was analyzed. Initial recurrence locations were identified, and imaging ... Read more >>

Urology (Urology)
[2020, 146:152-157]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

1.0415 s